The conversion of chemical energy into mechanical force by AAA1 (ATPases associated with diverse cellular activities) ATPases is integral to cellular processes, including DNA replication, protein unfolding, cargo transport and membrane fusion 1 . The AAA1 ATPase motor cytoplasmic dynein regulates ciliary trafficking 2 , mitotic spindle formation 3 and organelle transport 4 , and dissecting its precise functions has been challenging because of its rapid timescale of action and the lack of cell-permeable, chemical modulators. Here we describe the discovery of ciliobrevins, the first specific smallmolecule antagonists of cytoplasmic dynein. Ciliobrevins perturb protein trafficking within the primary cilium, leading to their malformation and Hedgehog signalling blockade. Ciliobrevins also prevent spindle pole focusing, kinetochore-microtubule attachment, melanosome aggregation and peroxisome motility in cultured cells. We further demonstrate the ability of ciliobrevins to block dynein-dependent microtubule gliding and ATPase activity in vitro. Ciliobrevins therefore will be useful reagents for studying cellular processes that require this microtubule motor and may guide the development of additional AAA1 ATPase superfamily inhibitors.
The AAA1 superfamily of enzymes couples ATP hydrolysis with the generation of mechanical force to regulate diverse aspects of prokaryote and eukaryote biology 1 . ATP-dependent conformational changes can propagate through these molecular machines to complete cellular processes within seconds, and chemical inhibitors that act rapidly and reversibly are much-needed tools for investigating the cellular functions of individual superfamily members. Yet, so far, only one AAA1 ATPase mechanoenzyme has been selectively targeted by a small molecule 5 .
We recently conducted a high-throughput screen for inhibitors of the Hedgehog (Hh) pathway ( Fig. 1a) 6 , a key mediator of embryonic development and oncogenesis 7 . Our study was designed to identify compounds that act downstream of Smoothened (Smo), a transmembrane Hh signalling protein, and one of the small molecules, HPI-4 ( Fig. 1b; 1) , blocked Hh pathway activation in cells lacking the negative regulator Suppressor of Fused (Sufu) 6 . Prolonged treatment of cells with this benzoyl dihydroquinazolinone also reduced the number and size of primary cilia, a microtubule-based extension of the plasma membrane that is required for Hh signalling 8 . Intrigued by these cellular phenotypes, we investigated the biochemical mechanism of HPI-4.
We first synthesized a series of analogues ( Fig. 1b ; 2-9) and evaluated their effects on Hh signalling and primary cilia formation (Fig. 1c, d and Supplementary Figs 1-3 ). Chemical derivatives lacking either a 3-or 4-chloro substituent on the benzoyl ring system (2 and 6) or the acyclic ketone (9) were significantly less active in either assay ( Fig. 1b, d) . The other small molecules segregated into 2,4-dichlorobenzoyl dihydroquinazolinones that inhibit both Hh signalling and primary cilia formation (1, (3) (4) (5) , which we henceforth name 'ciliobrevins A-D', and monochlorobenzoyl analogues that can block Hh target gene expression without inducing ciliary defects (7 and 8) ( Fig. 1b, d ).
Hh signalling is primarily mediated by the transcription factors Gli2 and Gli3, which exist in a pathway state-dependent balance of amino (N)-terminal repressors (Gli2/3R), full-length polypeptides (Gli2/3FL) and transcriptional activators (Gli2/3A) ( Fig. 1a) 7 . Both repressor and activator formation require the primary cilium 8 , and accordingly ciliobrevins altered the Gli3FL/Gli3R ratio in cells stimulated with the N-terminal domain of Sonic Hedgehog (Shh-N) ( Fig. 1e ; 30 mM doses of each compound). Shh-N-dependent Gli3FL phosphorylation was also reduced by these compounds, perhaps reflecting loss of Gli3A 9 . In contrast, none of the other analogues had a significant effect on the Gli3 processing or phosphorylation state ( Fig. 1e ).
To understand better the basis of these phenotypes, we took advantage of the temporal control afforded by chemical perturbations. Although prolonged exposure to these compounds causes defects in axonemal morphology, shorter treatments can divulge ciliobrevin-sensitive processes within structurally intact cilia. Because Hh pathway activation coincides with Gli2 accumulation at the distal ciliary tip 10 , we examined the effect of ciliobrevins on Gli2 localization ( Fig. 1f ). We incubated Hhresponsive cells with individual compounds at a 30 mM concentration in the absence or presence of Shh-N-conditioned medium for 4 h. Gli2 localization was unchanged by derivatives that do not significantly perturb ciliogenesis (2 and 8), whereas ciliobrevins A and D (1 and 5) induced ciliary Gli2 levels comparable to that in Shh-N-stimulated cells.
The ability of ciliobrevins to increase ciliary Gli2 levels suggests that these compounds might target protein trafficking mechanisms within this organelle. Intraflagellar transport (IFT) can be resolved into anterograde trafficking, which requires the plus-end-directed motor kinesin-2 and the IFTB multisubunit complex, and retrograde trafficking, which uses the minus-end-directed motor cytoplasmic dynein 2 and the IFTA complex 8 . Loss of the primary cilia-specific cytoplasmic dynein 2 heavy chain (Dync2h1) alters cilia morphology 11 , reduces Hh target gene expression 11 and increases ciliary levels of Gli2 10 . Similarities between these genetic phenotypes and the effects of ciliobrevins led us to hypothesize that these small molecules might inhibit cytoplasmic dynein 2. We therefore examined the effect of ciliobrevins on the subcellular localization of IFTB component IFT88, which requires cytoplasmic dynein 2-dependent retrograde transport for its return to the basal body. Treating cells for 1 hour with ciliobrevin D (5) but not DMSO or an inactive analogue (2) significantly increased IFT88 levels at the distal tip of primary cilia (Supplementary Fig. 4 ), providing further evidence that ciliobrevins inhibit cytoplasmic dynein 2 function.
Cytoplasmic dynein complexes have other cellular functions, including the crosslinking and focusing of microtubule minus ends within the mitotic spindle 3 . These actions create the fusiform shape and localize c-tubulin-containing complexes to the spindle poles 3 . Cytoplasmic dynein 1 inhibition by blocking antibodies or dominant-negative constructs perturbs spindle assembly, resulting in disorganized poles and reduced c-tubulin recruitment 3,12-14 . To determine whether ciliobrevins recapitulate these phenotypes, we treated a metaphaseenriched population of NIH-3T3 cells with 50 mM of either ciliobrevin D (5) or an inactive analogue (2) for 1 hour and examined their mitotic structures. Cells treated with ciliobrevin D showed abnormal (unfocused, multipolar or collapsed) spindles with disrupted c-tubulin localization ( Fig. 2a, b and Supplementary Fig. 5a ), whereas cells incubated with the non-cilia-disrupting analogue or vehicle alone showed normal spindle morphologies. Similar ciliobrevin-induced spindle defects were observed in HeLa cells, although to a lesser extent ( Fig. 2b ). Cytoplasmic dynein 1 is also required for establishing stable kinetochore-microtubule interactions 15 , and ciliobrevin D treatment disrupted the formation of cold-stable microtubules that mediate proper spindle-chromosome attachments ( Fig. 2c ).
To investigate if these spindle-disruptive effects were associated with altered dynein localization, we examined binding partners that recruit or co-localize with this motor. Immunofluorescence microscopy showed that p150-Glued, a dynactin component proposed to recruit dynein to kinetochores and spindle poles during mitosis 16 , was localized to the disorganized spindle poles of ciliobrevin D-treated cells ( Fig. 2d and Supplementary Fig. 5b ). Kinetochore targeting of p150-Glued was also unaffected by ciliobrevin D, as assessed in nocodazoletreated cells to obviate effects due to microtubule-attachment status 
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( Supplementary Fig. 6 ). We similarly observed that Zeste white 10 (Zw10), a component of the Rod/Zw10/Zwilch complex that recruits cytoplasmic dynein 1 to kinetochores 17 , and the kinetochore-associated protein Centromere protein E (CENP-E) 18 correctly localized to kinetochores under these conditions ( Supplementary Fig. 6 ), indicating that their recruitment and the kinetochore structure itself are not disrupted by ciliobrevins. Thus, ciliobrevin-induced spindle phenotypes most likely result from dynein inhibition rather than mislocalization.
To characterize further the mitotic defects associated with ciliobrevin treatment, we conducted real-time confocal microscopy of green fluorescent protein (GFP)-tubulin-expressing NIH-3T3 cells (Supplementary Figs 7, 8) . Within minutes of ciliobrevin D treatment, spindles collapsed, bipolarity was lost and spindle poles appeared disorganized ( Supplementary Fig. 7b ). Upon compound washout, bipolar spindles quickly re-emerged and chromosomes segregated at anaphase without any pronounced defects ( Supplementary Fig. 7c, d) . Ciliobrevin D addition also reversibly disrupted the pre-formed spindles of metaphase-arrested cells ( Supplementary Fig. 8b, c) and reduced overall microtubule levels ( Supplementary Fig. 8d ). These latter effects are mitosis-specific, as microtubule levels in non-dividing cells were unaffected by inhibitor treatment ( Supplementary Fig. 7e, f) . Taken together, these results reveal that cytoplasmic dynein is not only required for spindle pole assembly but also actively participates in its maintenance.
Cytoplasmic dynein 1 also regulates organelle trafficking, such as the melatonin-induced aggregation of melanosomes in Xenopus melanophores 19 . To determine if melanosome trafficking is sensitive to ciliobrevins, we cultured Xenopus melanophores with melanocytestimulating hormone to disperse these pigment granules and then treated the cells with melatonin and various concentrations of ciliobrevin D (5) or an inactive analogue (2) . Ciliobrevin D reversibly inhibited melanosome aggregation, but the non-cilia-disrupting derivative had no discernible effect at comparable doses (Fig. 3a, b and Supplementary Movies 1-3) . Ciliobrevin D similarly abrogated the movement of peroxisomes in Drosophila S2 cells (Fig. 3c-e and Supplementary Movies 4 and 5), consistent with the role of cytoplasmic dynein in their bidirectional motility 20 .
Collectively, these results indicate that ciliobrevins are specific, reversible inhibitors of disparate cytoplasmic dynein-dependent processes. Ciliobrevins do not perturb cellular mechanisms that are independent of dynein function, including actin cytoskeleton organization ( Supplementary Fig. 9 ) and the mitogen-activated protein kinase and phosphoinositol-3-kinase signalling pathways 6 . To examine more directly whether cytoplasmic dynein is the direct target of ciliobrevins, we evaluated their effects on dynein-dependent microtubule gliding in vitro. Ciliobrevins A and D (1 and 5) retarded the ATP-dependent (5) or an inactive derivative (2) for 10 min, stimulated with melatonin in the presence of the compounds for 30 min, and then paraformaldehyde-fixed. b, Melanophores treated with 5 as before, washed in medium containing melatonin alone, and then imaged. Scale bars, 100 mm. c, d, Motility of GFP-labelled peroxisomes in Drosophila S2 cells cultured in the absence (c) or presence (d) of 5. Overlays of videomicroscopy frames at t 5 0 s (red) and t 5 10 s (green) are shown. Scale bar, 5 mm. e, Vector distributions for the GFP-labelled peroxisomes with movement towards and away from the cell centre denoted by negative and positive bin values, respectively.
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movement of fluorescently labelled microtubules on bovine cytoplasmic dynein-coated glass slides in a reversible and dose-dependent manner (Fig. 4a-c, Supplementary Fig. 10 and Supplementary Movies 6-8); analogues that did not perturb cytoplasmic dynein-dependent processes in our cell-based assays (2 and 8) had minimal effects (Fig. 4a, b and Supplementary Movie 9). The conserved structure-activity relationships of dihydroquinazolinones in the microtubule gliding and cellbased assays confirm cytoplasmic dynein as the ciliobrevin target, and neither ciliobrevin A nor D significantly affected K560/kinesin-1-dependent microtubule gliding in vitro at 100 mM concentrations ( Fig. 4d and Supplementary Movies 10-12) . The compounds do not broadly target members of the AAA1 ATPase family either, as they have no effect on p97-dependent degradation of endoplasmic-reticulumassociated proteins ( Supplementary Fig. 11 ) or Mcm2-7-mediated DNA unwinding ( Supplementary Fig. 12 ).
We next investigated how ciliobrevins abrogate cytoplasmic dynein function. Neither ciliobrevin A nor D was able to disrupt the association between ADP-bound dynein and microtubules, as determined in a co-sedimentation assay ( Supplementary Fig. 13 ). Both small molecules, however, were able to inhibit the ATPase activity of bovine brain cytoplasmic dynein in a concentration-dependent manner, whereas their inactive analogue (2) could not ( Supplementary Fig. 14) . The compounds had analogous effects on the ATPase activity of recombinant rat dynein motor domain, but none significantly inhibited the ATPase activities of recombinant motor domains derived from human kinesin-1 or kinesin-5 (Fig. 4e) . Ciliobrevin efficacies at various ATP concentrations suggest that these small molecules act in a nucleotidecompetitive manner (Fig. 4f ). Consistent with this mechanism, ciliobrevin A also inhibited ultraviolet-light-induced cleavage of the cytoplasmic dynein motor domain in the presence of sodium vanadate and ATP ( Supplementary Fig. 15 ).
Our studies establish ciliobrevins as the first small molecules known specifically to inhibit cytoplasmic dynein in vitro and in live cells. Although the ATP analogue erythro-9-[3-(2-hydroxynonyl)]adenine 21 and the antioxidant nordihydroguaiaretic acid 22 have been previously reported to abrogate dynein function, these compounds are promiscuous enzyme antagonists 23, 24 . The natural product purealin can partly inhibit dynein ATPase activity in vitro 25 , but its ability to block cytoplasmic dynein-dependent cellular processes has not been demonstrated. Our studies indicate that ciliobrevins can inhibit both cytoplasmic dynein 1 and 2, and, accordingly, the compounds will be broadly applicable probes of dynein-dependent processes. Further development of ciliobrevin-like molecules could lead to isoformselective inhibitors of this minus-end-directed microtubule motor and perhaps specific antagonists of other AAA1 ATPase superfamily members.
METHODS SUMMARY
Hh signalling assays. Hh signalling and Gli3 processing assays were performed as described 6, 9 . Cell imaging. Cilia were immunostained with anti-Arl13b antibody (T. Caspary), and cilia size was determined by dividing the number of Arl13b-positive pixels by the number of nuclei per image. Ciliary levels of Gli2 and IFT88 were determined by immunostaining cells with anti-Gli2 (R&D Systems) or anti-IFT88 (ProteinTech Group) antibodies. Analyses of mitotic spindles and kinetochore-microtubule attachments in fixed cells were performed as described 26 , and real-time confocal microscopy was conducted with NIH-3T3 cells stably expressing GFP-tubulin. Melanosome and peroxisome motility studies were conducted as reported 19, 20 . Dynein activity assays. Bovine brain dynein was purified as described 27 , and its microtubule gliding activity was assayed as reported 28 with modifications. Recombinant rat cytoplasmic dynein motor domain was heterologously expressed and purified as described 29 
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